Biocon Gets Regulatory Nod To Use Drug Itolizumab On COVID-19 Patients
News: Biocon drug Itolizumab has been approved by the Drugs Controller General of India(DCGI) for treating moderate to severe Covid-19 patients. Facts: Itolizumab: It is a monoclonal antibody drug manufactured …
Read More